New options for testing and treating some of the most common sexually transmitted diseases are becoming available.

New offering expands screening options for cervical cancer and sexually transmitted infections (STIs), including chlamydia, gonorrhea, trichomonas or mycoplasma genitalium (Mgen) BURLINGTON, N.C., ...

New offering expands screening options for cervical cancer and sexually transmitted infections (STIs), including chlamydia, gonorrhea, trichomonas or mycoplasma genitalium (Mgen) BURLINGTON, N.C., ...

A sexually transmitted infection (STI) is passed from one person to another through sexual contact. An STI can have a viral cause, like human papillomavirus (HPV), or a bacterial cause, such as ...

STI rates show signs of decline, but stigma and disparities remain significant barriers to effective prevention and treatment. Untreated STIs can lead to severe health complications, including ...

In 2020, an estimated 82.4 million new gonorrhea infections occurred among adults aged 15–49 globally 1. Resistance Trends Gonococcal resistance has evolved across multiple antibiotic ...

STIs have affected humans for centuries, caused by diverse pathogens and manifesting in various syndromes. Despite medical advancements, the etiologies of some STI syndromes remain unexplained. These ...